Press Releases

Date	Title
7/29/10	AVI BioPharma to Present at BMO Capital Markets Focus on Healthcare Conference
7/20/10	AVI BioPharma Awarded up to $291 Million U.S. Government Contract for Advanced Development of Therapeutic Candidates for Ebola and Marburg Hemorrhagic Fever Viruses
7/16/10	AVI BioPharma Announces Presentations on Exon Skipping Drug AVI-4658 for Treatment of Duchenne Muscular Dystrophy at International Congress on Neuromuscular Diseases
7/16/10	AVI BioPharma Discloses New Contract With U.S. Government for Potential Funding of up to $291 Million to Advance Development of Therapeutic Candidates for Ebola and Marburg Hemorrhagic Fever Viruses
7/7/10	AVI BioPharma Opens Investigational New Drug (IND) Application for AVI-4658 in Duchenne Muscular Dystrophy
6/10/10	AVI BioPharma to Present at ThinkEquity's Mid Year Check-Up on Healthcare Conference
6/7/10	AVI BioPharma Discloses New Contract With U.S. Government for up to $18 Million to Advance Development of AVI-7100 as H1N1 Flu Therapeutic
6/3/10	AVI BioPharma to Present at the Jefferies 2010 Global Life Sciences Conference
5/11/10	AVI BioPharma to Present at the Rodman & Renshaw 6th Annual Global Healthcare Conference
5/10/10	AVI BioPharma Announces First Quarter 2010 Financial Results

IR Menu